• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Tufts CSDD Releases Findings from Diabetes Study

Article

Pharmaceutical Executive

September 26, 2016

According to results of a new study by the Tufts Center for the Study of Drug Development, the development process for new diabetes and non-diabetes endocrine drugs is riskier compared to all drug development. The study examined the development pathways and characteristics of 27 diabetes and 34 non-diabetes endocrine drugs.

Read the full release here

Recent Videos
Related Content
Peer Exchange: AI’s Data Advantage

Peer Exchange: AI’s Data Advantage

Mike Hollan
December 20th 2024
Article

In the third part of this roundtable discussion, experts discuss the issues with data that AI must overcome.

Peter Ax

Telehealth in 2025: Q&A with Peter Ax

Mike Hollan
December 19th 2024
Article

The Upscript Health CEO discusses trends in telehealth for the coming year.

DTC's New Era of Engagement

DTC's New Era of Engagement

Don Tracy, Associate Editor
December 16th 2024
Article

How alternative direct-to-consumer models are changing the landscape for patient access.

Holding On Tight to AI Wave

Holding On Tight to AI Wave

Mike Hollan
December 16th 2024
Article

The swell of AI-powered digital platforms puts future decision-making under the spotlight.

Introducing Agentic AI: Its Revolutionary Potential in Pharma

Introducing Agentic AI: Its Revolutionary Potential in Pharma

Tanveer Ahmed Nasir;Pooja Jain
December 13th 2024
Article

A look at the promise and opportunities from this new and advanced type of AI in transforming commercial planning and execution for life sciences companies.

Peer Exchange: Marketing With AI

Peer Exchange: Marketing With AI

Mike Hollan
December 13th 2024
Article

In the second part of this roundtable discussion, experts discuss how the industry is handling AI in the marketing space.